| Product Code: ETC7333163 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ghana Onco-hematology Molecular Testing Market Overview |
3.1 Ghana Country Macro Economic Indicators |
3.2 Ghana Onco-hematology Molecular Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Ghana Onco-hematology Molecular Testing Market - Industry Life Cycle |
3.4 Ghana Onco-hematology Molecular Testing Market - Porter's Five Forces |
3.5 Ghana Onco-hematology Molecular Testing Market Revenues & Volume Share, By Blood Cancer Type, 2021 & 2031F |
3.6 Ghana Onco-hematology Molecular Testing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 Ghana Onco-hematology Molecular Testing Market Revenues & Volume Share, By Blood Cancer Biomarker, 2021 & 2031F |
3.8 Ghana Onco-hematology Molecular Testing Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 Ghana Onco-hematology Molecular Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Growing prevalence of cancer and hematological disorders in Ghana |
4.2.2 Increasing awareness about the benefits of molecular testing for oncology and hematology |
4.2.3 Technological advancements in molecular testing leading to more accurate and efficient diagnostics |
4.3 Market Restraints |
4.3.1 Limited access to advanced molecular testing technologies in Ghana |
4.3.2 High costs associated with onco-hematology molecular testing |
4.3.3 Lack of skilled professionals for conducting and interpreting molecular tests |
5 Ghana Onco-hematology Molecular Testing Market Trends |
6 Ghana Onco-hematology Molecular Testing Market, By Types |
6.1 Ghana Onco-hematology Molecular Testing Market, By Blood Cancer Type |
6.1.1 Overview and Analysis |
6.1.2 Ghana Onco-hematology Molecular Testing Market Revenues & Volume, By Blood Cancer Type, 2021- 2031F |
6.1.3 Ghana Onco-hematology Molecular Testing Market Revenues & Volume, By Chronic Myeloid Leukemia, 2021- 2031F |
6.1.4 Ghana Onco-hematology Molecular Testing Market Revenues & Volume, By Myeloproliferative Neoplasms, 2021- 2031F |
6.1.5 Ghana Onco-hematology Molecular Testing Market Revenues & Volume, By Acute Myeloid Leukemia, 2021- 2031F |
6.1.6 Ghana Onco-hematology Molecular Testing Market Revenues & Volume, By Acute Lymphoblastic Leukemia, 2021- 2031F |
6.2 Ghana Onco-hematology Molecular Testing Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 Ghana Onco-hematology Molecular Testing Market Revenues & Volume, By qPCR, 2021- 2031F |
6.2.3 Ghana Onco-hematology Molecular Testing Market Revenues & Volume, By dPCR, 2021- 2031F |
6.2.4 Ghana Onco-hematology Molecular Testing Market Revenues & Volume, By Next-Generation Sequencing, 2021- 2031F |
6.2.5 Ghana Onco-hematology Molecular Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Ghana Onco-hematology Molecular Testing Market, By Blood Cancer Biomarker |
6.3.1 Overview and Analysis |
6.3.2 Ghana Onco-hematology Molecular Testing Market Revenues & Volume, By BCR-ABL1 Mbcr, 2021- 2031F |
6.3.3 Ghana Onco-hematology Molecular Testing Market Revenues & Volume, By JAK2, 2021- 2031F |
6.3.4 Ghana Onco-hematology Molecular Testing Market Revenues & Volume, By CALR, 2021- 2031F |
6.3.5 Ghana Onco-hematology Molecular Testing Market Revenues & Volume, By MPL, 2021- 2031F |
6.3.6 Ghana Onco-hematology Molecular Testing Market Revenues & Volume, By PML-RARA, 2021- 2031F |
6.3.7 Ghana Onco-hematology Molecular Testing Market Revenues & Volume, By NPM1, 2021- 2031F |
6.3.8 Ghana Onco-hematology Molecular Testing Market Revenues & Volume, By CBFB-MYH11, 2021- 2031F |
6.3.9 Ghana Onco-hematology Molecular Testing Market Revenues & Volume, By CBFB-MYH11, 2021- 2031F |
6.4 Ghana Onco-hematology Molecular Testing Market, By End-user |
6.4.1 Overview and Analysis |
6.4.2 Ghana Onco-hematology Molecular Testing Market Revenues & Volume, By National Reference Lab / Specialty Lab, 2021- 2031F |
6.4.3 Ghana Onco-hematology Molecular Testing Market Revenues & Volume, By University Hospital / Oncology Center, 2021- 2031F |
6.4.4 Ghana Onco-hematology Molecular Testing Market Revenues & Volume, By Community Hospital / IDN (Regional/National), 2021- 2031F |
7 Ghana Onco-hematology Molecular Testing Market Import-Export Trade Statistics |
7.1 Ghana Onco-hematology Molecular Testing Market Export to Major Countries |
7.2 Ghana Onco-hematology Molecular Testing Market Imports from Major Countries |
8 Ghana Onco-hematology Molecular Testing Market Key Performance Indicators |
8.1 Percentage increase in the adoption of molecular testing for oncology and hematology in Ghana |
8.2 Number of new partnerships or collaborations established for improving access to molecular testing technologies |
8.3 Rate of utilization of molecular testing in guiding treatment decisions for cancer and hematological disorders |
9 Ghana Onco-hematology Molecular Testing Market - Opportunity Assessment |
9.1 Ghana Onco-hematology Molecular Testing Market Opportunity Assessment, By Blood Cancer Type, 2021 & 2031F |
9.2 Ghana Onco-hematology Molecular Testing Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 Ghana Onco-hematology Molecular Testing Market Opportunity Assessment, By Blood Cancer Biomarker, 2021 & 2031F |
9.4 Ghana Onco-hematology Molecular Testing Market Opportunity Assessment, By End-user, 2021 & 2031F |
10 Ghana Onco-hematology Molecular Testing Market - Competitive Landscape |
10.1 Ghana Onco-hematology Molecular Testing Market Revenue Share, By Companies, 2024 |
10.2 Ghana Onco-hematology Molecular Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here